EpiVax receives $150,000 in phase II funding from Slater Center for Bio-Technology by epivax3 | Mar 25, 2003 | News | 0 comments Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website